- Home
- LYRA vs NAAS Comparison
LYRA vs NAAS Comparison
Compare LYRA & NAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYRA
- NAAS
- Stock Information
- Founded
- LYRA 2005
- NAAS 2019
- Country
- LYRA United States
- NAAS China
- Employees
- LYRA N/A
- NAAS N/A
- Industry
- LYRA Medical/Dental Instruments
- NAAS Other Specialty Stores
- Sector
- LYRA Health Care
- NAAS Consumer Discretionary
- Exchange
- LYRA Nasdaq
- NAAS Nasdaq
- Market Cap
- LYRA 11.3M
- NAAS 9.0M
- IPO Year
- LYRA 2020
- NAAS 2017
- Fundamental
- Price
- LYRA $6.37
- NAAS $3.45
- Analyst Decision
- LYRA Hold
- NAAS
- Analyst Count
- LYRA 1
- NAAS 0
- Target Price
- LYRA $16.00
- NAAS N/A
- AVG Volume (30 Days)
- LYRA 49.1K
- NAAS 74.6K
- Earning Date
- LYRA 11-11-2025
- NAAS 11-19-2025
- Dividend Yield
- LYRA N/A
- NAAS N/A
- EPS Growth
- LYRA N/A
- NAAS N/A
- EPS
- LYRA N/A
- NAAS N/A
- Revenue
- LYRA $770,000.00
- NAAS $21,817,052.00
- Revenue This Year
- LYRA N/A
- NAAS $378.49
- Revenue Next Year
- LYRA $106.28
- NAAS N/A
- P/E Ratio
- LYRA N/A
- NAAS N/A
- Revenue Growth
- LYRA N/A
- NAAS N/A
- 52 Week Low
- LYRA $3.81
- NAAS $1.96
- 52 Week High
- LYRA $37.50
- NAAS $55.84
- Technical
- Relative Strength Index (RSI)
- LYRA 39.68
- NAAS 48.30
- Support Level
- LYRA $6.25
- NAAS $3.13
- Resistance Level
- LYRA $7.30
- NAAS $4.19
- Average True Range (ATR)
- LYRA 0.60
- NAAS 0.35
- MACD
- LYRA -0.13
- NAAS -0.06
- Stochastic Oscillator
- LYRA 8.98
- NAAS 41.04
About LYRA Lyra Therapeutics Inc.
Lyra Therapeutics Inc is a clinical-stage therapeutics company focused on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients. The Company's operations and manages its business as a single operating segment which is the business of developing targeted medicines to address ears, nose, and throat, or ENT diseases. Its initial product candidates, LYR-210 and LYR-220, are bioabsorbable polymeric matrices designed to be administered in a brief, non-invasive, in-office procedure and intended to deliver continuous drug therapy to the sinonasal passages for the treatment of chronic rhinosinusitis, or CRS.
About NAAS NaaS Technology Inc.
Naas Technology Inc is an electric vehicle charging service provider in China, whose vision is to power the world with carbon-neutral energy. It offers an integrated set of online solutions to charging station operators, a wide range of offline services that simplify the daily operations of charging station operators, and non-charging services such as food and beverage services to station operators.